Exane Derivatives’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $837K | Sell |
|
|||||
|
2022
Q1 | $1.09M | Buy |
|
|||||
|
2021
Q4 | $1.07M | Buy |
|
|||||
|
2021
Q3 | $989K | Buy |
|
|||||
|
2021
Q2 | $316K | Sell |
|
|||||
|
2021
Q1 | $378K | Buy |
|
|||||
|
2020
Q4 | $312K | Sell |
|
|||||
|
2020
Q3 | $1.32M | Sell |
|
|||||
|
2020
Q2 | $2.53M | Buy |
|
|||||
|
2020
Q1 | $504K | Hold |
|
|||||
|
2019
Q4 | $432K | Sell |
|
|||||
|
2019
Q3 | $3.77M | Sell |
|
|||||
|
2019
Q2 | $4.05M | Sell |
|
|||||
|
2019
Q1 | $4.3M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $338K | Sell |
|
|||||
|
2017
Q4 | $1.03M | Sell |
|
|||||
|
2017
Q3 | $1.27M | Sell |
|
|||||
|
2017
Q2 | $1.13M | Buy |
|
|||||
|
2017
Q1 | $829K | Sell |
|
|||||
|
2016
Q4 | $1.38M | Sell |
|
|||||
|
2016
Q3 | $4.53M | Buy |
|
|||||
|
2016
Q2 | $1.47M | Buy |
|
|||||
|
2016
Q1 | $1.59M | Buy |
|
|||||
|
2015
Q4 | $1.1M | Buy |
|
|||||
|
2015
Q3 | $932K | Sell |
|
|||||
|
2015
Q2 | $23.9M | Buy |
|
|||||
|
2015
Q1 | $1.19M | Buy |
|
|||||
|
2014
Q4 | $928K | Buy |
|